Jeff P. Sharman, MD

Jeff P. Sharman, MD

Articles by Jeff P. Sharman, MD

Benefits of Pirtobrutinib Treatment in Patients With Chronic Lymphocytic Leukemia

Jeff P. Sharman, MDChronic Lymphocytic Leukemia | January 25, 2025

Jeff P. Sharman, MD, discusses pivotal findings from the phase III BRUIN CLL-321 trial.

Exploring Novel Mechanisms in Chronic Lymphocytic Leukemia

Jeff P. Sharman, MDChronic Lymphocytic Leukemia | January 24, 2025

Jeff P. Sharman, MD, explores unmet needs, prognosis, and novel treatments like pirtobrutinib in CLL.